Pillow with retractable umbrella
A pillow assembly having a supporting assembly and a retractable umbrella assembly that is easily transportable and allows a user to support his/her head while covering their face from sunlight.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 4331654 | Magnetically-localizable, biodegradable lipid microspheres Drug carrier formulation consisting of magnetically-localizable, biodegradable lipid microspheres.... | 05/25/1982 |
| 4323563 | Fat emulsion for intravenous injection A pharmaceutically acceptable emulsifier for preparing fat emulsions for intravenous injection comprising purified phospholipid of vegetable origin, containing less than 5% of glycolipid, and having a degree of hydrogenation of 30-50 as defined by the iod... | 04/06/1982 |
| 4321259 | Controlled improvement of the O2 -release by intact erythrocytes The invention provides erythrocytes of improved O2 -release properties having fused thereto small allosteric effectors, f.i. inositol hexaphosphate-containing lipid vesicles. Also included in the invention is a method for making said erythrocyt... | 03/23/1982 |
| 4312860 | Lung surfactant compositions A synthetic protein-free lung surfactant composition is utilized to temporarily substitute for natural lung surfactant in the mammalian lung where such natural lung surfactant is absent or in low concentration. The synthetic surfactant composition consist... | 01/26/1982 |
| 4309421 | Stabilized parenterally administrable solutions Solutions of anti-inflammatory acrylacetic and arylpropionic acid derivatives are stabilized by addition of phospholipids. The solutions are suitable for parenteral administration; they are well tolerated and have a long-lasting action.... | 01/05/1982 |
| 4280996 | Fat emulsion for intravenous injection A stable fat emulsion having low side effects, which is suitable as nutritive infusion fluid for intravenous injection, is provided. The emulsion contains 5-50 (W/V) % of soybean oil, yolk phospholipids in a weight ratio to the soybean oil of 1/4-1/25, 0.... | 07/28/1981 |
| 4263286 | Therapeutic agent for consciousness disorder and perception and movement disorder A therapeutic agent for treating consciousness disorder and perception and movement which comprises as an essential active ingredient a phosphatidic acid derivative selected from a phosphatidylcholine, a phosphatidic acid and a phosphatidylethanolamine in... | 04/21/1981 |
| 4252793 | Injectable lecithin preparation A method of preparing an injectable preparation of lecithin including 1 to 10% lecithin comprises the steps of separately preparing a lecithin fraction including lecithin and a non-hydrous liquid, separately preparing an aqueous fraction containing a surf... | 02/24/1981 |
| 4239754 | Liposomes containing heparin and a process for obtaining them Heparin-based preparations wherein heparin is retained in or on liposomes. The lipids of said liposomes are preferably phospholipids comprising acyl chains derived from non saturated fatty acids, advantageously essential acids. These heparin-liposomes preparat... | 12/16/1980 |
| 4221784 | Process and composition for treating disorders by administering lecithin Lecithin without a drug is administered to a patient in order to increase acetylcholine levels in the brain or other tissues, thereby to alleviate the effects of tardive dykinesia, manic-depressive disease, memory impairment or familial ataxias.... | 09/09/1980 |
| 4196202 | Carcinostatic composition containing 3-N-o-toluyl-5-fluorouracil producing the same Carcinostatic composition containing an oily substance such as a glyceride and 3-N-o-toluyl-5-fluorouracil suspended therein. The composition exhibits a remarkable carcinostatic effect against various cancerous cells at a low dose and has less side-effect... | 04/01/1980 |
| 4192869 | Controlled improvement of the O2 release by intact erythrocytes with lipid vesicles The invention provides erythrocytes of improved O2 -release properties having fused thereto small allosteric effectors, f.i. inositol hexaphosphate-containing lipid vesicles. Also included in the invention is a method for making said erythrocyt... | 03/11/1980 |
| 4119714 | Glycerin-alkylether-(1)-phosphoric acid-(3)-monocholine esters as enhancers of the natural resistance of the mammalian organism against non-carcinogenic pathogens Pharmaceutical compositions comprising as the active ingredient an ether-olecithin of the formula ##STR1## wherein R is alkyl of at least 12 and preferably 18 carbon atoms; the compositions are useful for enhancing the natural resistance of the ... | 10/10/1978 |